Grifols S.A
Research Grifols S.A (OZTA) on Bullrun: market cap EUR 6.66B, P/E 14.8, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOZTA
- ExchangeF
- CountrySpain
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencyEUR
- Market capEUR 6.66B
- P/E14.8
- Dividend yield0.8%
- Financial periodQ2 2026
- RevenueEUR 1.87B
- Net incomeEUR 154.00M
- Free cash flowEUR 108.00M
- Gross margin37.6%
Valuation Snapshot
latest market cap is EUR 6.66B; P/E is 14.8; dividend yield is 0.8%.
Peer valuation comparison
Latest P/E is 14.83x versus a Healthcare sector median of 24.46x (39.4% below).
Latest dividend yield is 0.82% versus a Healthcare sector median of 2.11% (61.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2024 | EUR 7.21B | EUR 212.81M | EUR 669.63M | 38.7% | 0.23 | EUR 979.78M | EUR 10.11B | EUR 5.88B |
| FY2023 | EUR 6.59B | EUR 163.67M | -EUR 5.75M | 37.7% | 0.06 | EUR 529.58M | n/a | EUR 5.37B |
| FY2022 | EUR 6.06B | EUR 247.90M | -EUR 285.23M | 36.5% | 0.27 | EUR 549.21M | n/a | EUR 5.65B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-15 | EUR 6.66B | 14.8 | 0.8% | 0.08 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.08 EUR, yield 0.8%.
About Grifols S.A
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others. The company offers various hemoderivatives from human plasma for immunology, infectious diseases, hepatology, intensive care, pulmonology, hematology, and neurology treatment areas;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Grifols S.A's market cap?
Grifols S.A's market capitalization is EUR 6.66B.
What is Grifols S.A's P/E ratio?
Grifols S.A's price-to-earnings (P/E) ratio is 14.8.
Does Grifols S.A pay a dividend?
Grifols S.A has a dividend yield of 0.8%.
What does Grifols S.A do?
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally. It operates through four segments: Biopharma, Diagnostic, Bio Supplies, and Others.